Chronic low back pain (CLBP) is a leading cause of disability, significantly impacting quality of life and work productivity. Traditional treatments often provide limited relief, necessitating alternative approaches. This multicenter, parallel-arm, randomized controlled trial (RCT) aims to evaluate the efficacy of Sphinx Pose Yoga Therapy (Yoga), Mindfulness-Based Stress Reduction (MBSR), and their combination in managing CLBP among healthcare providers (HCPs). Participants will be randomly assigned to one of four groups: Group A (Yoga Therapy): Sphinx Pose Yoga therapy, practiced three times per week. Group B (MBSR): Weekly mindfulness meditation, body scan, and gentle stretching. Group C (Usual Care): Standard treatment guidelines as per The Back Book. Group D (Combined Yoga \& MBSR): Integrated approach, practiced twice per week. The study will assess pain intensity, functional disability, quality of life, physiological markers, mental health, and heart rate variability. Outcomes will be measured at baseline (Week 0), post-intervention (Week 12), and follow-up (Week 24). The trial aims to determine whether Yoga, MBSR, or their combination provides superior benefits over usual care in CLBP management.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Enrollment
220
A structured yoga-based intervention focusing on the Sphinx Pose, aimed at improving spinal flexibility and reducing pain. Participants will perform three sessions per week for 12 weeks.
Malir University of Science & Technology
Karachi, Sindh, Pakistan
Pain Intensity
Measured using the Numerical Pain Rating (NPR) scale (0-10).
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
Functional Disability
Assessed via the Oswestry Low Back Pain Disability Questionnaire (0-100%).
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
Physiological Markers
Cortisol (stress response). β-Endorphins (BE) (pain modulation). Substance-P (SP) (pain neurotransmitter). Interleukin-6 (IL-6) and C-reactive protein (CRP) (inflammation).
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
Quality of Life (QoL)
Assessed using WHOQOL-BREF
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
Stress Levels
Measured by Sadaf Stress Scale (SSS) - Physical Stress Subscale.
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
Depression Symptoms
Evaluated via Beck Depression Inventory (BDI).
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
Anxiety Levels
Assessed using Generalized Anxiety Disorder 7 (GAD-7) scale.
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
Heart Rate Variability (HRV)
Measured via wearable biofeedback device.
Time frame: Baseline (Week 0), Post-Intervention (Week 12), Follow-up (Week 24).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.